Abbott Laboratories Pakistan Limited

Abbott Laboratories Pakistan Limited

PPSX:ABOT
1,005.00
PKR
+1.07
(+0.11%)
Feb 25Next Earn
Abbott Laboratories Pakistan Limited
PSX:ABOT
(Pakistan Stock Exchange)

Recent

price

1,005.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Abbott Laboratories (Pakistan) Limited, a healthcare company and majority-owned subsidiary of Abbott Asia Investments Limited under the ultimate parentage of Abbott Laboratories (USA), manufactures, imports, markets, and distributes pharmaceuticals, nutritional products, diagnostic systems, and general healthcare solutions. Founded in 1948 and headquartered in Karachi, Pakistan, the company operates across four primary business segments: Pharmaceuticals, Nutrition, Diagnostics, and Others. The Pharmaceuticals segment manufactures and commercializes prescription medicines and branded generics across major therapeutic areas, including pain management, gastroenterology, respiratory health, anti-infectives, cardiology, central nervous system disorders, women's health, and general anesthesia; offering established brands such as Brufen, Entamizole, Klaricid, Arinate, Surbex, Ganaton, Duspatalin, Prothiaden, Dilatrend, Duphaston, Creon, and Sevorane. The Nutrition segment provides science-based pediatric, maternal, adult, and specialized medical nutrition products; featuring core brands such as Ensure, Glucerna, PediaSure, Similac, and Isomil. The Diagnostics segment supplies automated core laboratory systems, clinical chemistry and immunoassay analyzers, hematology instruments, point-of-care testing equipment, and molecular assays and reagents; primarily anchored by the Alinity and ARCHITECT platform families. The Others segment markets diabetes care technologies, including blood glucose monitoring meters, test strips, and continuous glucose monitoring devices under the FreeStyle brand, alongside general medical consumables. The company serves retail pharmacies, public and private hospitals, primary healthcare institutions, diagnostic pathology centers, and end consumers across all provinces of Pakistan, while exporting finished pharmaceutical goods to regional markets in South Asia, the Middle East, and Africa. Abbott Laboratories (Pakistan) Limited operates two primary manufacturing plants located at Landhi and Korangi in Karachi. In recent developments, the company has accelerated investments in manufacturing automation, production line upgrades, and sustainability initiatives, including the deployment of industrial solar power installations across its Karachi facilities to enhance energy reliability and lower operational costs. To navigate macroeconomic challenges and regulatory developments established by the Drug Regulatory Authority of Pakistan (DRAP), the company has streamlined local procurement, optimized supply chain resilience, and introduced targeted formulation and packaging enhancements across its therapeutic portfolios. Additionally, the company has expanded its diagnostics market penetration through multi-site placements of next-generation Alinity analyzers in leading clinical networks, while scaling commercial distribution and healthcare professional engagement for its specialized adult and metabolic nutrition lines.